# Nanobiotix S.A.: Form 20-F for the period ended Dec 31, 2024

- Company: [Nanobiotix S.A.](/companies/nbtx.md) (CIK 1760854)
- Form: 20-F
- Filed: 2025-04-02
- Accepted by EDGAR: Apr 2, 2025, 16:18 ET
- Period: 2024-12-31
- Accession: 0001760854-25-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | −EUR 7.2m | ifrs-full:Revenue |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −EUR 68.4m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | EUR 101.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −EUR 68.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −EUR 1.44 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −EUR 1.44 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −EUR 19.6m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | EUR 846.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2024-12-31 | EUR 49.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2024-12-31 | EUR 61.5m | ifrs-full:CurrentAssets |
| Total assets | at 2024-12-31 | EUR 67.4m | ifrs-full:Assets |
| Current liabilities | at 2024-12-31 | EUR 58.9m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2024-12-31 | EUR 133.1m | ifrs-full:Liabilities |
| Shareholders' equity | at 2024-12-31 | −EUR 65.7m | ifrs-full:Equity |
| Shares outstanding | at 2024-12-31 | 47,426,851 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm

Filed Apr 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001760854-25-000005. Last ingested by Listed: Nov 10, 2026, 02:35 ET. No prices; not investment advice.